| 2007 | Gene expression profile related to prognosis of acute myeloid leukemia | 성주명; 이경은; 문영철 | Article |
| 2013 | Genome-wide genotype-based risk model for survival in acute myeloid leukaemia patients with normal karyotype | 문영철 | Article |
| 2013 | Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatment | 허정원; 문영철 | Article |
| 2011 | Immunoglobulin D multiple myeloma: Response to therapy, survival, and prognostic factors in 75 patients | 문영철 | Article |
| 2021 | Impact of depression on adherence to lenalidomide plus low-dose dexamethasone in patients with relapsed or refractory myeloma | 문영철 | Article |
| 2017 | Improved prognostic stratification using NCCN- and GELTAMOinternational prognostic index in patients with diffuse large B-cell lymphoma | 문영철 | Article |
| 2014 | Incidence of venous thromboembolism following major surgery in Korea: From the Health Insurance Review and Assessment Service database | 문영철 | Article |
| 2013 | KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement | 문영철 | Article |
| 2014 | Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea - Experience from 110 patients | 문영철 | Article |
| 2005 | Leukotriene B4 pathway regulates the fate of the hematopoietic stem cells | 성주명; 문영철 | Article |
| 2010 | Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide | 문영철 | Article |
| 2017 | Lymphedema associated with primary amyloidosis: A case study | 성순희; 한수정; 문영철 | Article |
| 2022 | Management of immune thrombocytopenia: 2022 update of Korean experts recommendations | 문영철; 박영훈 | Review |
| 2017 | Management of immune thrombocytopenia: Korean experts recommendation in 2017 | 문영철 | Review |
| 2013 | Matched-pair analysis to compare the outcomes of a second salvage auto-SCT to systemic chemotherapy alone in patients with multiple myeloma who relapsed after front-line auto-SCT | 문영철 | Article |
| 2011 | Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL) | 문영철 | Article |
| 2018 | Multicenter retrospective analysis of clinical characteristics, treatment patterns, and outcomes in very elderly patients with diffuse large B-cell lymphoma: The Korean cancer study group LY16-01 | 문영철 | Article |
| 2010 | Myelodysplastic syndrome mimicking idiopathic thrombocytopenic purpura | 정화순; 성주명; 허정원; 문영철 | Article |
| 2022 | Optimal timing of treatment at relapse after autologous stem cell transplantation in patients with multiple myeloma: a study of the Korean Multiple Myeloma Working Party (KMM-1909) | 문영철 | Article |
| 2020 | Peroxiredoxin 3 has important roles on arsenic trioxide induced apoptosis in human acute promyelocytic leukemia cell line via hyperoxidation of mitochondrial specific reactive oxygen species | 성주명; 유은선; 허정원; 이경은; 문영철; 남은미; 우현애 | Article |
| 2018 | Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150) | 문영철 | Article |
| 2017 | Phase III clinical trial (RERISE study) results of efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia | 문영철 | Article |
| 2022 | Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma | 이경은; 문영철 | Article |
| 2012 | Polymorphisms of ERCC1 genotype associated with response to imatinib therapy in chronic phase chronic myeloid leukemia | 문영철 | Article |
| 2007 | Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation | 성주명; 문영철 | Article |
| 2013 | Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib | 문영철 | Article |
| 2009 | Prognostic Factors and Clinical Outcomes of High-Dose Chemotherapy followed by Autologous Stem Cell Transplantation in Patients with Peripheral T Cell Lymphoma, Unspecified: Complete Remission at Transplantation and the Prognostic Index of Peripheral T Cell Lymphoma Are the Major Factors Predictive of Outcome | 문영철 | Article |
| 2012 | Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL) | 문영철 | Article |
| 2023 | Prognostic value of modified criteria for hydroxyurea resistance or intolerance in patients with high-risk essential thrombocythemia | 문영철; 박동진; 박영훈; 이세원 | Article |
| 2022 | Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma | 문영철 | Article |
